Dasatinib anhydrate containing oral formulation improves variability and bioavailability in humans.
Journal Information
Full Title: Leukemia
Abbreviation: Leukemia
Country: Unknown
Publisher: Unknown
Language: N/A
Publication Details
Related Papers from Same Journal
Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence textCore Indicators
Data Sharing
Code Sharing
COI Disclosure
Evidence found in paper:
"Competing interests JH, TH, GS, JB are employees of Zentiva, k.s., Prague, Czech Republic, that sponsored the development program."
Funding Disclosure
Evidence found in paper:
"This study was sponsored by Zentiva, k.s., Prague, Czech Republic. MS and OS have been supported by institutional support MH CZ – DRO – VFN00064165."
Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info
Tool: rtransparent
OST Version: N/A
Last Updated: Aug 05, 2025